Literature DB >> 20660358

Cross-priming: its beginnings.

Francis R Carbone1, William R Heath.   

Abstract

Mesh:

Substances:

Year:  2010        PMID: 20660358     DOI: 10.4049/jimmunol.1090065

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  5 in total

Review 1.  Capsid-incorporation of antigens into adenovirus capsid proteins for a vaccine approach.

Authors:  Qiana L Matthews
Journal:  Mol Pharm       Date:  2010-12-01       Impact factor: 4.939

Review 2.  Accum™ Technology: A Novel Conjugable Primer for Onco-Immunotherapy.

Authors:  Abed El-Hakim El-Kadiry; Simon Beaudoin; Sebastien Plouffe; Moutih Rafei
Journal:  Molecules       Date:  2022-06-13       Impact factor: 4.927

3.  Dendritic cells take up and present antigens from viable and apoptotic polymorphonuclear leukocytes.

Authors:  Carlos Alfaro; Natalia Suarez; Carmen Oñate; Jose L Perez-Gracia; Ivan Martinez-Forero; Sandra Hervas-Stubbs; Inmaculada Rodriguez; Guiomar Perez; Elixabet Bolaños; Asis Palazon; Miguel Fernandez de Sanmamed; Aizea Morales-Kastresana; Alvaro Gonzalez; Ignacio Melero
Journal:  PLoS One       Date:  2011-12-20       Impact factor: 3.240

4.  Deletion of Batf3-dependent antigen-presenting cells does not affect atherosclerotic lesion formation in mice.

Authors:  Jesus Gil-Pulido; Clement Cochain; Malte A Lippert; Nicole Schneider; Elke Butt; Núria Amézaga; Alma Zernecke
Journal:  PLoS One       Date:  2017-08-03       Impact factor: 3.240

5.  Promoting antigen escape from dendritic cell endosomes potentiates anti-tumoral immunity.

Authors:  Jean-Pierre Bikorimana; Natasha Salame; Simon Beaudoin; Mohammad Balood; Théo Crosson; Jamilah Abusarah; Sebastien Talbot; Raimar Löbenberg; Sebastien Plouffe; Moutih Rafei
Journal:  Cell Rep Med       Date:  2022-02-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.